Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP516220.RAlhxV5Yt-u04eziz9gJ4ldY1MUZLVizlBqEvh-6KLKI4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP516220.RAlhxV5Yt-u04eziz9gJ4ldY1MUZLVizlBqEvh-6KLKI4130_assertion type Assertion NP516220.RAlhxV5Yt-u04eziz9gJ4ldY1MUZLVizlBqEvh-6KLKI4130_head.
- NP516220.RAlhxV5Yt-u04eziz9gJ4ldY1MUZLVizlBqEvh-6KLKI4130_assertion description "[We resequenced TPH2 coding, 5' promoter, 3'-untranslated region, and splice junction regions in 190 individuals selected for ethnic and clinical diversity, determined haplotype structure using 15 single nucleotide polymorphisms spanning 106 kilobases (kb), and performed linkage analysis in 1798 cases and controls representing 4 populations (657 African Americans, including 104 suicide attempters and 135 with major depression; 513 Finnish whites, including 150 suicide attempters; 146 US whites, including 81 with depression, anxiety disorder, or both; and 482 southwestern American Indians, including 123 suicide attempters and 191 with depression, anxiety disorder, or both) and in 94 Finnish whites for cerebrospinal fluid 5-hydroxyindoleacetic acid levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP516220.RAlhxV5Yt-u04eziz9gJ4ldY1MUZLVizlBqEvh-6KLKI4130_provenance.
- NP516220.RAlhxV5Yt-u04eziz9gJ4ldY1MUZLVizlBqEvh-6KLKI4130_assertion evidence source_evidence_literature NP516220.RAlhxV5Yt-u04eziz9gJ4ldY1MUZLVizlBqEvh-6KLKI4130_provenance.
- NP516220.RAlhxV5Yt-u04eziz9gJ4ldY1MUZLVizlBqEvh-6KLKI4130_assertion SIO_000772 16203956 NP516220.RAlhxV5Yt-u04eziz9gJ4ldY1MUZLVizlBqEvh-6KLKI4130_provenance.
- NP516220.RAlhxV5Yt-u04eziz9gJ4ldY1MUZLVizlBqEvh-6KLKI4130_assertion wasDerivedFrom befree-2016 NP516220.RAlhxV5Yt-u04eziz9gJ4ldY1MUZLVizlBqEvh-6KLKI4130_provenance.
- NP516220.RAlhxV5Yt-u04eziz9gJ4ldY1MUZLVizlBqEvh-6KLKI4130_assertion wasGeneratedBy ECO_0000203 NP516220.RAlhxV5Yt-u04eziz9gJ4ldY1MUZLVizlBqEvh-6KLKI4130_provenance.